 |
 |
- About Us
- Early Phase
- Overview
- Exploratory Clinical Trials
- First-in-Human Clinical Trials
- Regulatory Phase I Trials
- Clinical Pharmacokinetic and Pharmacodynamics Support
- Biotechnology Development Hub
- Bioanalysis-Method Development Validation
- Regulatory Affairs Expertise
- Pharmacovigilance
- Clinical Data Management
- Biostatistics
- Medical Writing
- Clinical Research Facilities
- Late Phase
- Overview
- Clinical Trial Management
- Pharmaceutical Regulatory Affairs
- Pharmacovigilance and Medical Affairs Services
- Health Economics and Outcomes Research
- Electronic Data Capture (EDC) Services
- Clinical Data Management System
- Clinical Biostatistics
- Medical Writing Services
- Outsourcing: Clinical Trial Temporary Staffing
- Lab Services
- Therapeutic Expertise
- Investigator Portal
- Volunteers
- Contact
WINNING IS AN ATTITUDE. Winners leave nothing to chance. Teamwork and experience are key. Selecting the right partner can favorably impact your drug development timelines. SGS has 30 years of experience as a global CRO, providing integrated solutions from preclinical activities to Phase I-IV trials, bioanalytical and QC testing. Learn how your team can reach its clinical development goals.
 
Understanding and detection of immunogenicity can have important implications for the the successful development and marketing of biotech drugs. Join this webinar to learn about emerging technologies .
 
There are currently three different procedures that can be used to submit a medicinal product for marketing approval in the European Union. Download this paper to learn about the available avenues.
|
|
|
 |
|
|
